Company News in the Life Science Industry

»

Reset 

Alkermes Announces Recipients of 1st Annual ALKERMES PATHWAYS RESEARCH AWARDS (SM) Program

DUBLIN, Jan. 16, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the recipients of the ALKERMES PATHWAYS RESEARCH AWARDS(SM)... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Five Fifty Fifty, World's Only Run/Walk Series Running 50 5Ks in 50 Days in All 50 States, Sets April 27 for Official Kick Off

DELAFIELD, Wis., Jan. 16, 2019 /PRNewswire/ -- In an effort to raise awareness for the prevalence of mental health issues in the U.S. while also reinforcing the power of fitness to help overcome mental illness, the second annual Five Fifty Fifty Run/Walk for Mental Health Series has announced... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

CannaTech: Panama -- World's Top Medical Cannabis Scientists and Business Leaders to Gather at Panama's First Medical Cannabis Conference February 12-13, 2019

TEL AVIV, Israel, Jan. 16, 2019 /PRNewswire/ -- The world's leading cannabis researchers and scientists, ag-tech, pharma experts, regulators, investors, and entrepreneurs will share their knowledge about the burgeoning medical cannabis industry at CannaTech Panama, Panama's first ever international... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Acurx Receives FDA Fast Track Designation for ACX-362E for the Treatment of C. difficile infection

WHITE PLAINS, N.Y., Jan. 16, 2019 /PRNewswire/ -- Acurx Pharmaceuticals, LLC ("Acurx" or the "Company"), a clinical stage, privately-held biopharmaceutical company focused on developing new antibiotics for difficult-to-treat bacterial infections, announced today that the U.S. Food and Drug Administration... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Applied Spectral Imaging (ASI) reveals advanced FISH solutions that deliver ultra-fast imaging analysis

CARLSBAD, Calif., Jan. 16, 2019 /PRNewswire/ -- Applied Spectral Imaging (ASI), a global leader and provider of biomedical imaging analysis solutions has launched a new product update to facilitate the growing demands of pathology and cytogenetic laboratories.

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  Applied Spectral Imaging, Inc.

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry

CLEVELAND, Jan. 16, 2019 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy (MRT) dosimetry.

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2019

HepVu Releases State-Level Maps Showing Impact of Hepatitis C Epidemic Across the U.S.

ATLANTA, Jan. 16, 2019 /PRNewswire/ -- Today, HepVu launched new interactive maps visualizing state-level estimates of people living with Hepatitis C across the United States that highlight a concentration of infections in some states most impacted by the opioid epidemic. Published in Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  Albany Molecular Research Inc., Grafton, Wisconsin (U.S.A.) | Albany Molecular Research Inc. | Albany Molecular Research Inc., Burlington, Massachusetts

American Family Care Named to Franchise 500 List for Sixth Consecutive Year

BIRMINGHAM, Ala., Jan. 16, 2019 /PRNewswire/ -- For the sixth consecutive year, American Family Care (AFC) has earned a spot on Entrepreneur magazine's Franchise 500®, one of the world's most admired business rankings. This year, AFC is ranked #107 on the distinguished list, continuing a steady... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Poll finds 86% of Americans Take Vitamins or Supplements Yet Only 21% Have a Confirmed Nutritional Deficiency

CHICAGO, Jan. 16, 2019 /PRNewswire/ -- More than 4 in 5 American adults (86 percent) take vitamins or supplements, according to a recent online survey conducted by The Harris Poll on behalf of the American Osteopathic Association. However, only about a quarter (24 percent) of those taking vitamins... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  THE AMERICAN OSTEOPATHIC ASSOCIATION

Praxid, New Natural Breakthrough Product For Digestive Wellness Disrupts PPIs And Heartburn Drug Industry

MIAMI, Jan. 16, 2019 /PRNewswire/ -- In the past, those who suffer from chronic, severe gastroesophageal reflux disease (known as GERD) have relied on proton pump inhibitor (PPIs) medications that were never intended for extended periods of time. In fact, long term use of these medications has... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Blue Cross and Blue Shield of Texas Awards More Than $1.8 million To Fight Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease

RICHARDSON, Texas, Jan. 16, 2019 /PRNewswire/ -- In a continuing commitment to help fight and raise awareness around preventing and managing Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Anesthesia Business Consultants to Exhibit at the ASA's PRACTICE MANAGEMENT(TM) Conference 2019

JACKSON, Mich., Jan. 16, 2019 /PRNewswire/ -- Anesthesia Business Consultants (ABC), a leading provider in billing... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Histofluor® Rodent Tissue Slides receive FDA 510(k) clearance

SACRAMENTO, Calif., Jan. 16, 2019 /PRNewswire/ -- Immuno Concepts, a recognized pioneer in innovation of autoimmune diagnostic reagents and instrumentation, is pleased to announce that the United States Food and Drug Administration (FDA), through the 510(k) process, has cleared the Histofluor®... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy

SILVER SPRING, Md., Jan. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  U.S. Food and Drug Administration

ClinOne's Video E-Consent: Helping Bring the Trial to the Patient

DENVER, Jan. 16, 2019 /PRNewswire/ -- Informed consent is one of the most important aspects of clinical research ethics. Ensuring that the patient is protected and well informed is essential. Yet, it's estimated that more than 1/3 of all eligible patients for a clinical trial won't consent due... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

Global Sleep Apnea Devices Market 2016-2018 & 2023 - Growing Adoption of Wearable Sleep Trackers

DUBLIN, Jan 16, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2019

National Partners in Healthcare Partners with Anesthesia Resources

PHOENIX, Jan. 16, 2019 /PRNewswire/ -- National Partners in Healthcare (NPH), a national healthcare organization delivering best in class anesthesiology services, announced today that Anesthesia Resources (AR) has joined NPH.

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2019

The REAM Foundation launches research funding program for misophonia

WASHINGTON, Jan. 16, 2019 /PRNewswire/ -- The REAM Foundation, in collaboration with the Milken Institute's Center for Strategic Philanthropy, today announced the launch of the first dedicated misophonia grant program to encourage scientific progress, better understand the condition, and develop... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  MILKEN INSTITUTE

Standard Wellness Opens The Forest in Sandusky, Serves First Patient in Ohio

SANDUSKY, Ohio, Jan. 16, 2019 /PRNewswire/ -- At 9am today, Ynez Henningsen, a multiple sclerosis patient and first-time cannabis consumer, became the first patient in Ohio to be served by the state's medical marijuana program. Henningsen made the state's first legal purchase at The Forest... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019

AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial

IRVINE, Calif., Jan. 16, 2019 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1B clinical trial investigating... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2019
Related companies:  AiVita Biomedical, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies